Other Events ·
GeoVax Labs Inc. received a Staff Determination Letter from Nasdaq notifying the company of its intent to delist…
GOVXWGeoVax Labs, Inc.
GeoVax Labs Inc. received a Staff Determination Letter from Nasdaq notifying the company of its intent to delist common stock due to failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days ending August 26, 2026. The company also failed to meet the $2,500,000 stockholders’ equity requirement. Because GeoVax executed a 1-for-25 reverse stock split on January 12, 2026, it is ineligible for the standard 180-day compliance period. Trading may be suspended starting September 8, 2026, if no hearing request is filed; however, the company plans to appeal before the September 3 deadline, which will stay further actions and allow continued trading during the process. GeoVax Labs Inc. operates in the biotechnology industry, focusing on vaccine development.